The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study

The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study

The selection of candidates for the curative treatment of PCa requires a careful assessment of life expectancy. Recently, blood-count inflammatory markers have been introduced as prognosticators of oncological and non-oncological outcomes in different settings. This retrospective, monocentric study...

Full description

Bibliographic Details
Main Authors: Piotr Zapała, Karolina Garbas, Zbigniew Lewandowski, Łukasz Zapała, Aleksander Ślusarczyk, Cezary Ślusarczyk, Łukasz Mielczarek, Piotr Radziszewski
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
prostate cancer
life expectancy
systemic immune-inflammation index
Charlson comorbidity index
CAPRA-S
early survival
Online Access:https://www.mdpi.com/2072-6694/14/17/4135

Internet

https://www.mdpi.com/2072-6694/14/17/4135

Similar Items